Asthma and allergic diseases are among the most common chronic diseases in both children and adults. The Center for Asthma Research, directed by Tina Hartert, MD, MPH, focuses on understanding the developmental origins of asthma, and how asthma and allergic diseases may be prevented and treated.
 
Who We Are and What We Do
The Center’s clinical-translational team is composed of over 50 investigators, post-doctoral fellows, nurses, research assistants, students, and has collaborations with over twenty academic institutions worldwide. We firmly believe that the long-term solution to the asthma epidemic is primary and secondary disease prevention. The Center for Asthma Research takes a bedside to bench translational approach that:

 

• Focuses on causal risk factors for asthma and allergic disease development
• Develops and tests primary, secondary, and tertiary prevention strategies
• Shares a common goal to improve the respiratory health of people worldwide
• Trains the next generation of scientists

• Glucagon-like Peptide-1 Receptor Agonist in the Treatment of Adult, Obesity-related, Symptomatic Asthma (GATA-3) clinical trial. PI: Kathryn Cahill, MD
• Modification of the Early-Life Respiratory Microbiome Through Vaginal Seeding (MOTHERSEED) PI: Christian Rosas-Salazar, MD, MPH
• Molecular Pathways in Childhood Asthma Pathogenesis. PI: Brittney Snyder, PhD
• RSV and Respiratory Morbidity in Children w/ Down-Syndrome. PI: Pingsheng Wu, PhD, MS
• Systems Biology of Early Atopy (SUNBEAM). PI: Len Bacharier, MD
• Pregnancy E-cigarette Use and Adverse Birth Outcomes. PI: Pingsheng Wu, PhD, MS
• NIH Asthma and Allergic Disease Cooperative Research Centers. PI: Stokes Peebles, MD and Tina Hartert, MD, MPH
• NIH Human Epidemiology and Response to SARS-CoV-2 (HEROS). PI: Tina Hartert, MD, MPH
• NIH Environmental Influences on Child Health Outcomes (ECHO-CREW Asthma Consortium). PI: Tina Hartert, MD, MPH

For information on how to contact us, job opportunties, and more, please check out our website! 

• William Obremskey, MD, MPH, MMHC: PO Versus IV Antibiotics for the Treatment of Infected Nonunion of Fractures After Fixation, Congressionally Directed Medical Research Programs
• Paul Harris, PhD: ICERCH-Supporting the HEAL Pain ERN, U24/NIH/NCATS
• Eric Grogan, MD, MPH: Clinical Utility of a Combined Biomarker Approach to Diagnose Lung Cancer, U01/NIH/NCI
• Wesley Self, MD, MPH: Surveillance of Acutely Ill Adults with Respiratory Viruses, including SARS-CoV-2 (IVY 5), Centers for Disease Control and Prevention
• Adam Wright, PhD: Machine Learning-Driven Interactive Value Set Enhancement System (MALDIVES), R01/NIH/NLM
• Adriana Hung, MD, MPH: A Phase 2/3 Adaptive, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of VX-147 in Subjects Aged 12 Years and Older With APOL1-mediated Proteinuric Kidney Disease, Vertex Pharmaceuticals Inc.